These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19622099)

  • 1. Modulation of inhibitory neurotransmission in brainstem vagal circuits by NPY and PYY is controlled by cAMP levels.
    Browning KN; Travagli RA
    Neurogastroenterol Motil; 2009 Dec; 21(12):1309-e126. PubMed ID: 19622099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
    Browning KN; Travagli RA
    J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
    Chen CH; Stephens RL; Rogers RC
    Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal afferent control of opioidergic effects in rat brainstem circuits.
    Browning KN; Zheng Z; Gettys TW; Travagli RA
    J Physiol; 2006 Sep; 575(Pt 3):761-76. PubMed ID: 16825311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptor trafficking on inhibitory synapses in the rat brainstem.
    Browning KN; Kalyuzhny AE; Travagli RA
    J Neurosci; 2004 Aug; 24(33):7344-52. PubMed ID: 15317860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticity in the brainstem vagal circuits controlling gastric motor function triggered by corticotropin releasing factor.
    Browning KN; Babic T; Toti L; Holmes GM; Coleman FH; Travagli RA
    J Physiol; 2014 Oct; 592(20):4591-605. PubMed ID: 25128570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
    Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
    J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peptide TRH uncovers the presence of presynaptic 5-HT1A receptors via activation of a second messenger pathway in the rat dorsal vagal complex.
    Browning KN; Travagli RA
    J Physiol; 2001 Mar; 531(Pt 2):425-35. PubMed ID: 11230515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats.
    Yoneda M; Nakamura K; Yokohama S; Tamori K; Sato Y; Aso K; Aoshima M; Kono T; Makino I
    Hepatology; 1998 Sep; 28(3):670-6. PubMed ID: 9731557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin-releasing peptide affects gastric motor function in rat by modulating synaptic transmission in the dorsal vagal complex.
    Grabauskas G; Zhou SY; Das S; Lu Y; Owyang C; Moises HC
    J Physiol; 2004 Dec; 561(Pt 3):821-39. PubMed ID: 15486017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-glucose modulates synaptic transmission from the central terminals of vagal afferent fibers.
    Wan S; Browning KN
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G757-63. PubMed ID: 18202107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP-dependent insulin modulation of synaptic inhibition in neurons of the dorsal motor nucleus of the vagus is altered in diabetic mice.
    Blake CB; Smith BN
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R711-20. PubMed ID: 24990858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional organization of presynaptic metabotropic glutamate receptors in vagal brainstem circuits.
    Browning KN; Travagli RA
    J Neurosci; 2007 Aug; 27(34):8979-88. PubMed ID: 17715335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for peptide YY and neuropeptide Y on guinea pig pancreatic acini.
    Huang SC; Tsai MF
    Peptides; 1994; 15(3):405-10. PubMed ID: 7524045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
    Serone AP; Wright CE; Angus JA
    Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide YY and the Y2 agonist PYY-(13-36) inhibit neurons of the dorsal motor nucleus of the vagus.
    Chen CH; Rogers RC
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R213-8. PubMed ID: 9249552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.